To include your compound in the COVID-19 Resource Center, submit it here.

Sumitomo Dainippon Pharma Co. Ltd, DKSH deal

The companies added commercialization rights to a deal under which DKSH was responsible for obtaining regulatory

Read the full 165 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE